Clinical features and treatment outcomes of non-hodgkin's lymphomas involving rare extranodal sites: A single-center experience

Acta Haematologica

Volumn 123, Issue 1, 2009, Pages 48-54

  Yun, Jina ^a   Kim, Seok Jin ^a   Kim, Jung A ^a   Kong, Jee Hyun ^a   Lee, Soo Hyeon ^a   Kim, Kihyun ^a   Ko, Young Hyeh ^a   Kim, Won Seog ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Extranodal lymphomas; Non Hodgkin's lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADRENAL CANCER; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG TREATMENT FAILURE; ESOPHAGUS CANCER; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL TIME; TREATMENT OUTCOME; UTERUS CANCER;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PREDNISONE; PROGNOSIS; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 70849104211     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000262291     Document Type: Article

References (17)

1. Freeman C, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252-260.
2. Zucca E, Roggero E, Bertoni F, Cavalli F: Primary extranodal non-Hodgkin's lymphomas. 1. Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-737.
3. Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F: Primary extranodal non-Hodgkin's lymphomas. 2. Head and neck, central nervous system and other less common sites. Ann Oncol 1999; 10: 1023-1033.
4. Chiu BC, Weisenburger DD: An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 2003; 4: 161-168.
5. Cavalli F, Stein H, Zucca E (eds): Extranodal Lymphomas, Pathology and Management. London, Informa, 2008.
6. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L: Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980; 46: 215-222.
7. D'Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, Pedersen M, Jensen MK, Johansen P, Andersen E, Bach B, Sorensen E, on behalf of the Danish LYFO Study Group: Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer 1991; 27: 1201-1208.
8. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
9. Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM: Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003; 14: 131-139.
10. Dawson IM, Cornes JS, Morson BC: Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961; 49: 80-89.
11. Kosari F, Daneshbod Y, Parwaresch R, Krams M, Wacker HH: Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol 2005; 29: 1512-1520.
12. Lagoo AS, Robboy SJ: Lymphoma of the female genital tract: current status. Int J Gynecol Pathol 2006; 25: 1-21.
13. Osborne BM, Robboy SJ: Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. Cancer 1983; 52: 1933-1943.
14. Wang J, Sun NC, Renslo R, Chuang CC, Tabbarah HJ, Barajas L, French SW: Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol 1998; 58: 130-136.
15. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ: Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol 1993; 17: 154-170.
16. Koniaris LG, Lillemoe KD, Yeo CJ, Abrams RA, Colemann J, Nakeeb A, Pitt H, Cameron JL: Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg 2000; 190: 319-330.
17. Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, Lopez-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379-391.